查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1363121

结核病诊断市场规模、份额、趋势分析报告：按测试类型、最终用途、地区、细分趋势，2023-2030 年

Tuberculosis Diagnostics Market Size, Share & Trends Analysis Report By Test Type (Radiographic Method, Diagnostic Laboratory Methods, Nucleic Acid Testing, Phage Assay), By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10个工作天内

价格

结核病诊断市场成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球结核病诊断市场规模预计将达到33.4亿美元，2023年至2030年年复合成长率为5.2%。

干扰素γ释放测定（IGRA）、血清学技术和核酸检测等先进诊断技术的出现导致了诊断剂的高利用率。此外，抗原检测等护理点 (POC) 技术也提高了结核病诊断率。

这些先进的方法，包括 POC 诊断，价格实惠、准确、方便，并且可以快速提供结果。此外，结核病负担的增加是推动市场成长的主要要素。根据世界卫生组织（WHO）估计，2014年全球结核病患者人数约960万人。这种高患病促使政府、医疗机构、研究机构和市场相关人员采取措施遏制这种感染疾病的爆发。

发展重点是提高高负担地区的筛检率、负担得起的诊断、先进的调查方法、快速的临床决策和降低死亡率。提高预防性和治疗性诊断率是这些配合措施的最终结果。因此，诊断测试的需求迅速增加，结核病诊断市场不断扩大。

结核病诊断市场报告亮点

  • 根据检验类型，结核病诊断市场分为X光检测、实验室诊断、核酸检测、噬菌体检测、潜伏感染检测、细胞激素检测及抗药性检测。
  • 由于其成本效益和易于执行，诊断实验室测试在测试类型领域占据主导地位，2015 年市场占有率为 38.0%。诊断实验室测试包括涂片显微镜检查和基于培养的测试。高负担地区缺乏采用先进技术并依赖这些方法的财政和技术能力，从而促进了诊断实验室检测领域的成长。
  • 然而，准确度低和处理时间长是此诊断方法的限制要素。因此，医疗保健组织努力在发展中地区实施先进技术。
  • 因此，核酸检测领域和潜在感染疾病检测领域，包括皮肤检测和IGRA，可能呈现盈利成长率。这些方法透过克服上述限制来提高诊断的负担能力、处理时间和准确性。
  • 结核病的抗药性是医疗专业人员关注的主要问题之一，因为错误的用药方案或错误的剂型导致的不当治疗会导致结核病患者在治疗过程中产生抗药性。因此，抗药性检测领域也预计将呈现良好的成长动能。
  • 亚太地区人口众多，结核病罹患率率高，在2015年主导了全球结核病诊断市场。世界卫生组织表示，印度、中国、阿富汗和印尼等国家是控制这场疫情的优先地区。
  • 结核病检测市场的参与者包括 Thermo Fisher Scientific, Inc.、Hologic Corporation、Abbott Laboratories、Alere, Inc.、Becton、Dickinson and Company、F. Hoffmann-La Roche AG、bioMerieux SA、Sanofi、Cepheid、Hain Lifescience GmbH、包括凯杰。
  • 新产品发布、合作、併购和区域扩张是这些产业参与者采取的关键策略措施。
  • 例如，2016年7月，生物梅里埃推出了用于结核病鉴定的新型CE标誌资料库和试剂组VITEK MS。该新产品的推出预计将有助于该公司扩大市场占有率。

目录

第1章调查方法和范围

第2章执行摘要

第3章结核病诊断市场变数、趋势、范围

  • 市场体系预测
    • 母市场预测
    • 相关/附随市场预测
  • 普及和成长预测图
  • 市场动态
    • 市场促进因素分析
    • 市场抑制因素分析
  • 结核病诊断市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第4章结核病诊断：检测类型的估计和趋势分析

  • 结核病诊断市场：要点
  • 结核病诊断市场：2022 年和 2030 年趋势和市场占有率分析
  • 射线照相
  • 诊断测试方法
  • 核酸检测
  • 噬菌体测定
  • 检测潜伏感染（皮肤试验和IGRA）
  • 细胞激素检测分析
  • 抗药性检测（DST）
  • 其他的

第5章结核病诊断：按最终用途的估计和趋势分析

  • 结核病诊断市场：要点
  • 结核病诊断市场：2022 年和 2030 年趋势和市场占有率分析
  • 诊断实验室
  • 医院和诊所
  • 其他的

第6章结核病诊断市场：区域估计与趋势分析

  • 区域展望
  • 按地区分列的结核诊断市场：要点
  • 北美洲
    • 2018-2030 年市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 科威特

第7章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 市场参与企业分类
    • Abbott Laboratories
    • Becton, Dickinson and Company
    • F. Hoffmann-La Roche AG
    • Thermo Fisher Scientific Inc.
    • BioMerieux SA
    • Hain Lifescience GmbH
    • QIAGEN GmbH
    • Cepheid
    • Hologic, Inc.
    • BD
Product Code: GVR-1-68038-098-9

Tuberculosis Diagnostics Market Growth & Trends:

The global tuberculosis diagnostics market size is expected to reach USD 3.34 billion by 2030, registering a CAGR of 5.2% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Advent of advanced diagnostic methods such as Interferon-gamma Release Assay (IGRA), serological methods, and nucleic acid testing have resulted in the high usage rate of diagnostics. Moreover, Point of Care (POC) technologies such as antigen assays are also promoting the diagnosis rate of TB.

These advanced methods including POC diagnostics are affordable, accurate, simple, and yield quick results. Furthermore, the rising burden of TB is the primary factor responsible for the lucrative market growth. As per the World Health Organization, the global estimates of patients afflicted with TB were around 9.6 million in 2014. This high prevalence rate has led the government, healthcare organizations, research institutes, and market players to initiate endeavors directed toward containing the incidence of this infectious disease.

The increasing screening rate in the high burden regions, affordability of diagnostics, advanced methodologies, faster clinical decisions, and reduction in mortality rate are the focal areas of development. Improved preventive and curative diagnosis rates are the end results of these initiatives. This has led to a subsequent upsurge in the demand for diagnostic tests and the TB diagnostics market.

Tuberculosis Diagnostics Market Report Highlights:

  • Based on tests type, the tuberculosis diagnostics market is segmented into radiographic methods, diagnostic laboratory methods, nucleic acid testing, phage assay, detection of latent infection, cytokine detection assay, and detection of drug resistance.
  • Diagnostic laboratory tests dominated the test type segment with 38.0% market share in 2015 as they are cost efficient and easy-to-perform. Diagnostic laboratory tests include smear microscopy and culture-based tests. The high burden regions rely on these methodologies due to their financial and technical incapability to incorporate advanced technologies thus contributing to the growth of the diagnostic laboratory tests segment.
  • However, compromised accuracy and the longer processing time are the limiting factor for the diagnostics. Hence, healthcare agencies are striving to implement advanced techniques in the developing regions.
  • As a result, nucleic acid tests segment and the latent infection detection segment, which includes skin tests and IGRA, are likely to exhibit a profitable growth rate. These methods overcome the aforementioned limitations thus improving affordability, processing time and accuracy of the diagnostic method.
  • Drug resistance in tuberculosis is one of the primary concerns for healthcare professionals as improper treatment due to wrong drug regimen and incorrect dosage forms lead to the development of drug resistance in TB patients undergoing treatment. Hence, the drug resistance detection segment is also anticipated to witness lucrative growth.
  • Asia Pacific owing to its huge population base and high burden of TB dominated the global TB diagnostics market in 2015. As per the WHO, countries such as India, China, Afghanistan, and Indonesia are priority regions for control of this communicable disease.
  • The players in the TB testing market include Thermo Fisher Scientific, Inc., Hologic Corporation, Abbott Laboratories, Alere, Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche AG, bioMerieux SA, Sanofi, Cepheid, Hain Lifescience GmbH, and QIAGEN.
  • New product launches, collaboration, mergers & acquisitions, and regional expansion are the key strategic initiatives undertaken by these industry players
  • For instance, in July 2016, bioMerieux launched a novel CE marked database and reagents kit VITEK MS for the identification of TB. This new product launch is anticipated to help the company increase its market share.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Test Type
    • 1.1.2. End-use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Test type outlook
    • 2.2.2. End-use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Tuberculosis Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Tuberculosis Diagnostics Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Tuberculosis Diagnostics: Test Type Estimates & Trend Analysis

  • 4.1. Tuberculosis Diagnostics Market: Key Takeaways
  • 4.2. Tuberculosis Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Radiographic Method
    • 4.3.1. Radiographic method market estimates and forecasts, 2018 to 2030, (USD Million)
  • 4.4. Diagnostic Laboratory Methods
    • 4.4.1. Diagnostic laboratory methods market estimates and forecasts, 2018 to 2030, (USD Million)
  • 4.5. Nucleic Acid Testing
    • 4.5.1. Nucleic acid testing market estimates and forecasts, 2018 to 2030, (USD Million)
  • 4.6. Phage Assay
    • 4.6.1. Phage assay market estimates and forecasts, 2018 to 2030, (USD Million)
  • 4.7. Detection of Latent Infection (Skin Test & IGRA)
    • 4.7.1. Detection of latent infection market estimates and forecasts, 2018 to 2030, (USD Million)
  • 4.8. Cytokine Detection Assay
    • 4.8.1. Cytokine detection assay market estimates and forecasts, 2018 to 2030, (USD Million)
  • 4.9. Detection of Drug Resistance (DST)
    • 4.9.1. Detection of drug resistance (DST) market estimates and forecasts, 2018 to 2030, (USD Million)
  • 4.10. Other Methods
    • 4.10.1. Other methods market estimates and forecasts, 2018 to 2030, (USD Million)

Chapter 5. Tuberculosis Diagnostics: End-use Estimates & Trend Analysis

  • 5.1. Tuberculosis Diagnostics Market: Key Takeaways
  • 5.2. Tuberculosis Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Diagnostic Laboratories
    • 5.3.1. Diagnostic laboratories market estimates and forecasts, 2018 to 2030, (USD Million)
  • 5.4. Hospitals & Clinics
    • 5.4.1. Hospitals & clinics market estimates and forecasts, 2018 to 2030, (USD Million)
  • 5.5. Others
    • 5.5.1. Others market estimates and forecasts, 2018 to 2030, (USD Million)

Chapter 6. Tuberculosis Diagnostics Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Tuberculosis Diagnostics Market by Region: Key Takeaways
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. Abbott Laboratories
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Becton, Dickinson and Company
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. F. Hoffmann-La Roche AG
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Thermo Fisher Scientific Inc.
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. BioMerieux SA
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Hain Lifescience GmbH
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. QIAGEN GmbH
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Cepheid
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. Hologic, Inc.
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. BD
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 3 North America tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 4 North America tuberculosis diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 6 U.S. tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 Canada tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 8 Canada tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Europe tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 10 Europe tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 11 Europe tuberculosis diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 13 Germany tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 14 UK tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 15 UK tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 France tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 17 France tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 18 Italy tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 19 Italy tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Spain tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 21 Spain tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 Sweden tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 23 Sweden tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Norway tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 25 Norway tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 Denmark tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 27 Denmark tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific tuberculosis diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 31 China tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 32 China tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 Japan tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 34 Japan tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 India tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 36 India tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Australia tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 38 Australia tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 Thailand tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 40 Thailand tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 South Korea tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 42 South Korea tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Latin America tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 44 Latin America tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 Latin America tuberculosis diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 47 Brazil tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Mexico tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 49 Mexico tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Argentina tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 51 Argentina tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa tuberculosis diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 56 South Africa tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 UAE tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 60 UAE tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait tuberculosis diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 62 Kuwait tuberculosis diagnostics market, by end-use, 2018 - 2030 (USD Million) 

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Tuberculosis diagnostics: Market outlook
  • Fig. 9 Tuberculosis diagnostics: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Tuberculosis diagnostics market driver impact
  • Fig. 15 Tuberculosis diagnostics market restraint impact
  • Fig. 16 Tuberculosis diagnostics market strategic initiatives analysis
  • Fig. 17 Tuberculosis diagnostics market: Test type movement analysis
  • Fig. 18 Tuberculosis diagnostics market: Test type outlook and key takeaways
  • Fig. 19 Radiographic method market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Diagnostic laboratory methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Nucleic acid testing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Phage assay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Detection of latent infection (skin test & IGRA) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Cytokine detection assay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Detection of drug resistance (DST) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Other methods market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Tuberculosis diagnostics market: End-use movement analysis
  • Fig. 28 Tuberculosis diagnostics market: End-use outlook and key takeaways
  • Fig. 29 Diagnostic laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Hospitals & clinics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Global tuberculosis diagnostics market: Regional movement analysis
  • Fig. 33 Global tuberculosis diagnostics market: Regional outlook and key takeaways
  • Fig. 34 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)